Home/Filings/4/0001209191-22-027153
4//SEC Filing

Hunder Naomi 4

Accession 0001209191-22-027153

CIK 0001671858other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 5:07 PM ET

Size

7.1 KB

Accession

0001209191-22-027153

Insider Transaction Report

Form 4
Period: 2022-05-02
Hunder Naomi
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-05-02+43,17754,427 total
  • Award

    Stock Option (right to buy)

    2022-05-02+86,35586,355 total
    Exercise: $3.15Exp: 2032-05-01Common Stock (86,355 underlying)
Footnotes (2)
  • [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The shares subject to the option will vest on May 2, 2023.

Issuer

Silverback Therapeutics, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001832170

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:07 PM ET
Size
7.1 KB